NCT00381758
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
Not specified
Clinical trial condition
Attention Deficit Disorder with Hyperactivity
Explore clinical trials studying Attention Deficit Disorder with Hyperactivity. Study availability and eligibility vary by location and protocol.
1,407 public trials
158 recruiting studies
Attention Deficit Disorder with Hyperactivity trial results
NCT00001915
- Conditions
- Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +13 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00001544
- Conditions
- Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +15 more
- Locations
-
- National Institute of Mental Health (NIMH) Bethesda, Maryland, United States
NCT00001497
- Conditions
- Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +25 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00619840
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
- Institute of Forensic Psychology and Psychiatry Homburg/Saar, Saarland, Germany
NCT00254878
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
- Novartis Investigational Site Freiburg im Breisgau, Germany
NCT00301236
- Conditions
- ADHD, ADD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
- Novartis Investigational Site Mesa, Arizona, United States
- Novartis Investigational Site Little Rock, Arkansas, United States
- Novartis Investigational Site Los Angeles, California, United States
- Novartis Investigational Site Boulder, Colorado, United States
NCT00141050
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
- Bayou City Research Houston, Texas, United States
NCT00141063
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
- Center for Psychiatry & Behavioral Medicine Las Vegas, Nevada, United States
NCT00190736
- Conditions
- ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Lafayette, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Spring Valley, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Farmington, Connecticut, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Hamden, Connecticut, United States